Celestine S. Tung

772 total citations
24 papers, 590 citations indexed

About

Celestine S. Tung is a scholar working on Pulmonary and Respiratory Medicine, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Celestine S. Tung has authored 24 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Reproductive Medicine and 6 papers in Molecular Biology. Recurrent topics in Celestine S. Tung's work include Ovarian cancer diagnosis and treatment (8 papers), Renal cell carcinoma treatment (4 papers) and Maternal and fetal healthcare (2 papers). Celestine S. Tung is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Renal cell carcinoma treatment (4 papers) and Maternal and fetal healthcare (2 papers). Celestine S. Tung collaborates with scholars based in United States and Egypt. Celestine S. Tung's co-authors include Amy B. Middleman, Kwong‐Kwok Wong, Samuel C. Mok, Karen H. Lu, Roberta Anding, David M. Gershenson, Yvonne T.M. Tsang, Zhifei Zu, Michael T. Deavers and Judith K. Wolf and has published in prestigious journals such as PEDIATRICS, International Journal of Molecular Sciences and American Journal of Obstetrics and Gynecology.

In The Last Decade

Celestine S. Tung

22 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celestine S. Tung United States 11 207 182 135 132 128 24 590
Anne Van Arsdale United States 12 148 0.7× 91 0.5× 120 0.9× 126 1.0× 121 0.9× 25 588
Limor Gortzak‐Uzan Israel 9 250 1.2× 220 1.2× 72 0.5× 103 0.8× 73 0.6× 19 599
Samir Hidar Tunisia 16 163 0.8× 307 1.7× 80 0.6× 158 1.2× 282 2.2× 59 818
Eralp Başer Türkiye 14 170 0.8× 112 0.6× 53 0.4× 83 0.6× 120 0.9× 44 523
Randi A. Paynter United States 15 138 0.7× 143 0.8× 119 0.9× 125 0.9× 31 0.2× 19 680
Anthony Proietto Australia 16 133 0.6× 53 0.3× 114 0.8× 106 0.8× 164 1.3× 41 671
Tomasz Banaś Poland 17 430 2.1× 81 0.4× 68 0.5× 149 1.1× 284 2.2× 69 821
Min Hao China 15 202 1.0× 109 0.6× 96 0.7× 58 0.4× 114 0.9× 55 596
Kahindo P. Muyayalo China 12 264 1.3× 106 0.6× 87 0.6× 121 0.9× 74 0.6× 22 587
Michelle Wise New Zealand 17 486 2.3× 125 0.7× 140 1.0× 219 1.7× 194 1.5× 60 815

Countries citing papers authored by Celestine S. Tung

Since Specialization
Citations

This map shows the geographic impact of Celestine S. Tung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celestine S. Tung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celestine S. Tung more than expected).

Fields of papers citing papers by Celestine S. Tung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celestine S. Tung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celestine S. Tung. The network helps show where Celestine S. Tung may publish in the future.

Co-authorship network of co-authors of Celestine S. Tung

This figure shows the co-authorship network connecting the top 25 collaborators of Celestine S. Tung. A scholar is included among the top collaborators of Celestine S. Tung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celestine S. Tung. Celestine S. Tung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tung, Celestine S., et al.. (2021). A Gigantic Uterine Leiomyoma and Big Bilateral Adrenal Myelolipomas as a Result of Untreated Congenital Adrenal Hyperplasia. AACE Clinical Case Reports. 7(6). 342–345. 1 indexed citations
2.
Coffey, Donna, et al.. (2018). Successful yolk-sac tumor treatment with fertility-sparing partial oophorectomy. Gynecologic Oncology Reports. 27. 22–24. 5 indexed citations
3.
Sharma, Shelly, et al.. (2018). Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer. International Journal of Gynecological Cancer. 28(5). 1003–1012. 8 indexed citations
4.
Erfani, Hadi, Karin A. Fox, Kelsey A. Stewart, et al.. (2018). 169: Unexpected Placenta Accreta Spectrum (PAS): Improved outcomes with Multidisciplinary Team Care. American Journal of Obstetrics and Gynecology. 220(1). S127–S127.
5.
Miller, Heather, et al.. (2017). The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy. Journal of Minimally Invasive Gynecology. 24(5). 772–776. 10 indexed citations
6.
Shamshirsaz, Alireza A., Karin A. Fox, Hadi Erfani, et al.. (2017). Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. American Journal of Obstetrics and Gynecology. 216(6). 612.e1–612.e5. 161 indexed citations
7.
Fleming, Nicole D., Robert L. Coleman, Celestine S. Tung, et al.. (2017). Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer. Gynecologic Oncology. 147(1). 41–46. 16 indexed citations
8.
Westin, Shannon N., Charlotte C. Sun, Celestine S. Tung, et al.. (2015). Survivors of gynecologic malignancies: impact of treatment on health and well-being. Journal of Cancer Survivorship. 10(2). 261–270. 59 indexed citations
9.
Bradford, Andrea, et al.. (2015). Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers. Gynecologic Oncology. 139(1). 134–140. 26 indexed citations
10.
Song, Huijuan, Zhifei Zu, Yvonne T.M. Tsang, et al.. (2013). PAX2 Expression in Ovarian Cancer. International Journal of Molecular Sciences. 14(3). 6090–6105. 22 indexed citations
11.
Tung, Celestine S., Charlotte C. Sun, Robin A. Lacour, et al.. (2013). Sleep disturbances: A critical issue among gynecologic cancer survivors. Gynecologic Oncology. 130(1). e7–e7. 1 indexed citations
12.
King, Erin R., Celestine S. Tung, Yvonne T.M. Tsang, et al.. (2011). The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated With Differentiation and Survival in Ovarian Cancer. The American Journal of Surgical Pathology. 35(6). 904–912. 86 indexed citations
13.
Huang, Monica L., Shannon N. Westin, Charlotte C. Sun, et al.. (2011). Menopausal symptoms and use of hormone replacement therapy: The gynecologic cancer survivors' perspective. Gynecologic Oncology. 120. S82–S82.
14.
Middleman, Amy B., Roberta Anding, & Celestine S. Tung. (2010). Effect of Needle Length When Immunizing Obese Adolescents With Hepatitis B Vaccine. PEDIATRICS. 125(3). e508–e512. 46 indexed citations
15.
Tung, Celestine S., Charlotte C. Sun, Matthew Schlumbrecht, Larissa A. Meyer, & Diane C. Bodurka. (2009). Survival after intestinal perforation: Can it be predicted?. Gynecologic Oncology. 115(3). 349–353. 3 indexed citations
16.
Tung, Celestine S., Haleh Sangi‐Haghpeykar, & Judy Levison. (2009). Rapid versus standard testing for prenatal HIV screening in a predominantly Hispanic population. Journal of Perinatology. 30(1). 30–32. 6 indexed citations
17.
Tung, Celestine S., Samuel C. Mok, Yvonne T.M. Tsang, et al.. (2009). PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Modern Pathology. 22(9). 1243–1250. 75 indexed citations
18.
Tung, Celestine S., Israel Zighelboim, Bradford G. Scott, & Matthew L. Anderson. (2006). Human acellular dermal matrix for closure of a contaminated gynecologic wound. Gynecologic Oncology. 103(1). 354–356. 5 indexed citations
19.
Middleman, Amy B., Celestine S. Tung, & Roberta Anding. (2006). 3: Does needle length affect titer level achieved after hepatitis B immunization among overweight youth?. Journal of Adolescent Health. 38(2). 101–101. 3 indexed citations
20.
Tung, Celestine S. & Amy B. Middleman. (2005). An evaluation of school-level factors used in a successful school-based hepatitis B immunization initiative. Journal of Adolescent Health. 37(1). 61–68. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Van Arsdale Breakdown of academic impact, for papers by Limor Gortzak‐Uzan Breakdown of academic impact, for papers by Samir Hidar Breakdown of academic impact, for papers by Eralp Başer Breakdown of academic impact, for papers by Randi A. Paynter Breakdown of academic impact, for papers by Anthony Proietto Breakdown of academic impact, for papers by Tomasz Banaś Breakdown of academic impact, for papers by Min Hao Breakdown of academic impact, for papers by Kahindo P. Muyayalo Breakdown of academic impact, for papers by Michelle Wise
Rankless by CCL
2026